www.fdanews.com/articles/114832-shire-acquires-rights-to-adhd-drug

Shire Acquires Rights to ADHD Drug

February 20, 2009

Pharmaceutical firm Shire has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL, used for the treatment of attention deficit hyperactivity (ADHD).
ShareCast